North Thames NHS Genomic Medicine Centre (NTGMC)
The North Thames GMC was established to help gain a better understanding of the genetic causes of cancer and rare disease.
The NTGMC is currently one of 13 regional GMCs in England as part of the Government’s 100,000 Genomes Project which aims to sequence, or analyse, 100,000 genomes from participants with cancer, rare disorders and infectious diseases.
The aims of the centres are to help medical teams provide better diagnosis or treatment for patients, create a comprehensive medical research resource, stimulate the development of new therapies and support a new era of personalised medicine.
The North Thames GMC is made up of seven hospital trusts, supported by UCLPartners:
- Great Ormond Street Hospital for Children NHS Foundation Trust (lead trust)
- Barts Health NHS Trust
- London North West Healthcare NHS Trust
- Moorfields Eye Hospital NHS Foundation Trust
- Royal Free London NHS Foundation Trust
- Royal National Orthopaedic Hospital NHS Trust
- University College London Hospitals NHS Foundation Trust (UCLH)
The North Thames GMC is the biggest centre in the country and is expected to contribute 10,000 rare disease genomes and 5,000 cancer genomes – a significant proportion of the overall national project.
To find out more, visit the North Thames Genomic Medicine Centre website.